Related Experiment Video
Updated: Apr 25, 2026

The Chick Chorioallantoic Membrane CAM Model as a Tool to Study Ovarian Tissue Transplantation
Published on: June 23, 2023
Biomedical subjectivities and reproductive assumptions in the CAMELIA clinical trial in Cambodia
1a Institut de Recherche pour le Développement, International Research Unit UMI 233 TransVIHMI Translational Research applied to HIV and infectious diseases , 911, avenue Agropolis, Montpellier , BP 64501 F-3439 France.
Abstract:
The inclusion of women in clinical trials has raised a variety of ethical and practical issues in their implementation. In the recent CAMELIA clinical trial in Cambodia, the inclusion criteria included a negative pregnancy test and signature of the consent form confirming commitment to double contraceptive use as patients were given drugs contra-indicated in case of pregnancy. But despite precautions and the requirement stated in the informed consent form, 19 out of 236 enrolled women became pregnant during the trial. The current paper describes the frictions and subjectivities that emerge as new medical technologies travel to resource-poor settings--and more specifically, how trial researchers, health workers, and research subjects involved in the CAMELIA trial negotiate the injunction to avoid pregnancy while using a teratogenic drug.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bias in Epidemiological Studies
Ethics in Research

